Chronic lymphocytic leukemia: planning for an aging population - Wikidata - wikimedia - TriplyDB

Chronic lymphocytic leukemia: planning for an aging population

Chronic lymphocytic leukemia: planning for an aging population

http://www.wikidata.org/entity/Q34560909

about

Management of Chronic Lymphocytic Leukemia in the Elderly Therapeutic potential of new B cell-targeted agents in the treatment of elderly and unfit patients with chronic lymphocytic leukemia Acadesine for patients with relapsed/refractory chronic lymphocytic leukemia (CLL): a multicenter phase I/II study Treatment practice in the elderly patient with chronic lymphocytic leukemia-analysis of the combined SEER and Medicare database.Treatment of elderly patients with chronic lymphocytic leukemia: an unmet cinical need.Integrating oncogeriatric tools into the management of chronic lymphocytic leukemia: current state of the art and challenges for the future.Idelalisib for the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma.Can ex vivo evaluation (testing) predict the sensitivity of CLL cells to therapy with purine analogs in conjunction with an alkylating agent? A comparison of in vivo and ex vivo responses to treatment.Relapsed chronic lymphocytic leukemia retreated with rituximab: interim results of the PERLE study.Renal insufficiency is an independent prognostic factor in patients with chronic lymphocytic leukemia.Increased risk of chronic lymphocytic leukaemia among cancer survivors in the Netherlands: increased detection, causal factors or both?Hematologic malignancies: an opportunity to fill a gap in cancer surveillance.Comparison of the mRNA expression profile of B-cell receptor components in normal CD5-high B-lymphocytes and chronic lymphocytic leukemia: a key role of ZAP70.Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings.

P2860

Q26775983-49D310F6-3F88-43CF-A8C3-476C74C0E64C Q28087378-A3D1EE3F-F241-4616-ABFC-BB9C3C34C70B Q33404763-BAAE1B9A-F657-4AAA-A629-E3A821A8209A Q33846793-0D65D070-2195-41DD-BE23-0B7BFF1EE790 Q38132818-B6F6A7AA-F854-476F-A3B4-D4D07EFDC8C6 Q38489690-6AB667D3-D639-4D4B-984D-A87FA2712CBD Q38850667-C2C4AA93-29FA-40C9-BE45-161B403C0B94 Q39442429-FD7E4A03-672A-49E3-8BA0-96B654E0EDD9 Q40303819-2ABA0756-3C73-4384-B021-B802459E8F3F Q42334355-E21830E9-D342-44DE-B2DF-D6F9EBCF26C0 Q42635534-CA54562E-7FF9-4E52-B7FD-5D32B798CE53 Q43676080-511B8440-9E7E-4CB8-936A-DD0FBF406537 Q47105863-3E6E9DF9-6D2E-4635-A4AE-BF4E3CD19421 Q48304637-3D21F962-AEE9-4D7D-878B-054DA289D683

P2860

Chronic lymphocytic leukemia: planning for an aging population

http://www.wikidata.org/entity/Q34560909

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Chronic lymphocytic leukemia: planning for an aging population

@ast

Chronic lymphocytic leukemia: planning for an aging population

@en

Chronic lymphocytic leukemia: planning for an aging population

@nl

type

label

Chronic lymphocytic leukemia: planning for an aging population

@ast

Chronic lymphocytic leukemia: planning for an aging population

@en

Chronic lymphocytic leukemia: planning for an aging population

@nl

prefLabel

Chronic lymphocytic leukemia: planning for an aging population

@ast

Chronic lymphocytic leukemia: planning for an aging population

@en

Chronic lymphocytic leukemia: planning for an aging population

@nl

P1433

Q34560909-3070123C-F84D-4652-9774-14423BCF3642

P1476

Q34560909-9BE30874-794A-4D98-9915-DCFBB456F605

P2093

Q34560909-F02A63A0-4E49-45B5-8AC9-A7FD45F6C0F0

P2860

Q34560909-0018A922-1708-47F2-9DC1-748F88C34D3F

Q34560909-041C6A32-EC93-40FF-93F7-5485E0054B0F

Q34560909-09DAC9A3-BFD4-46F3-91BE-E0B9AFA3493D

Q34560909-11D3548F-6610-48A3-8135-BED0D4A6CEB0

Q34560909-11F3A5A4-366E-4642-A8EC-33048BEC7CE1

Q34560909-2D3A5314-1E92-4E03-BB28-F567803C4058

Q34560909-34E53B8A-805D-456D-AD96-6DA686BA862E

Q34560909-3AD8BBB4-B79A-4DCA-A17E-66E3CBCB3650

Q34560909-3DC8D8A4-1826-43EB-B447-BEE95BDE3449

Q34560909-3F13E8F5-7CA0-4104-9D68-D80BA99094ED

P304

Q34560909-186107FB-F678-4ADC-A9D0-DCFE8CE2EC96

P31

Q34560909-44F99BC8-EF7A-43B0-B7D1-B0215E760ABB

P356

Q34560909-3A69D69E-6497-42C6-A630-04854862438D

P433

Q34560909-4D082B41-6AA5-465C-A56B-B5B2D9558083

P478

Q34560909-7B113BE0-6A58-42E3-85D4-0E7D01B24815

P577

Q34560909-2D0F6629-8979-4B2B-9E89-5843F6C25C7E

P698

Q34560909-A134C738-76D6-4CD5-B221-25024C551303

P921

Q34560909-6738F95A-35BC-4F14-9C58-F685E413E778

Q34560909-EF8FFCE5-11CB-4724-B1B7-59799738A947

P932

Q34560909-DF475225-59E9-43C8-B23C-41BED3054D5E

P356

P1433

Expert Review of Anticancer Therapy

P1476

Chronic lymphocytic leukemia: planning for an aging population

@en

P2093

John G Gribben

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia

Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial.

Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia.

Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997.

Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia

How I treat CLL up front.

How to measure comorbidity. a critical review of available methods.

P304

1389-1394

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERA.10.127

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20836674

http://www.w3.org/2001/XMLSchema#string

P921

P932

4241366

http://www.w3.org/2001/XMLSchema#string